RecruitingNot ApplicableNCT07167264

PGHD-AI Intelligent Model for the Nutritional Assessment and Intervention of Patients After Radical Surgery for Pancreatic Cancer.

Evaluation of a Combined PGHD-AI Intelligent Model for the Nutritional Assessment and Intervention of Patients After Radical Surgery for Pancreatic Cancer.

Sponsor

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

Enrollment

200 participants

Start Date

Jul 16, 2025

Study Type

INTERVENTIONAL

Conditions

Pancreatic Cancer

Summary

This study will collect patient PRO (physical strength, pain, defecation, appetite, weight, etc.) data through the APP, use corpus collection cards, facial photography and other technologies to collect PGHD characteristic phenotypes, and then combine artificial intelligence technology to train and cultivate agents (agents) to carry out joint offline routine follow-up of patients after radical pancreatic cancer resection to evaluate the feasibility of nutritional risk assessment intervention. Thus, the feasibility of artificial intelligence prediction of health status is verified, and an efficient follow-up tool and nutritional support evaluation plan are provided for the management of pancreatic cancer patients throughout the course of the disease, so as to improve the treatment prognosis and quality of life of pancreatic cancer patients.

Eligibility

Min Age: 18 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This study is testing whether an AI-powered app that uses patient-generated health data (like weight, meals, and symptoms tracked on a phone) can improve nutrition and recovery for people after surgery for pancreatic cancer. Poor nutrition is a major challenge after this type of surgery and can slow recovery. **You may be eligible if...** - You are between 18 and 80 years old - You have been diagnosed with pancreatic cancer and had radical (curative-intent) surgery - You have fully recovered from surgery at the time of study enrollment - You are in reasonably good functional health (ECOG score 0 or 1) - You and your family are willing to use the smartphone app **You may NOT be eligible if...** - Your pancreatic cancer has spread (metastatic) or has come back - You have had another cancer in the past - You have serious organ dysfunction (severe liver, kidney, or heart problems) - You are pregnant or breastfeeding Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERPGHD's AI intelligent model(APP)

To collect patient PRO (physical strength, pain, defecation, appetite, weight, etc.) data through the PGHD's AI intelligent model(APP), and use corpus collection cards, facial photography and other technologies to collect PGHD characteristic phenotypes.

Locations(1)

Shanghai General Hospital

Shanghai, Shanghai Municipality, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07167264

Related Trials

DESTINY-PANTUMOUR04

NCT0712400017 locations

Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)

NCT0725223217 locations

In-Depth Characterisation of Biliary Strictures and Hepato-Pancreato-Biliary Focal Lesions for Development of New Technologies to Tackle Hepato-Pancreato-Biliary Cancers

NCT072063551 location

Incremental Value of Magnetic Resonance Imaging in Selection of Pancreatic Cancer Patients for Surgery

NCT054283583 locations

Nutritional Intervention Implication in Enhanced Recovery After Surgery for Whipple Procedure

NCT075605401 location